BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1327387)

  • 21. Role of histamine in rodent antinociception.
    Malmberg-Aiello P; Lamberti C; Ghelardini C; Giotti A; Bartolini A
    Br J Pharmacol; 1994 Apr; 111(4):1269-79. PubMed ID: 8032614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic studies on the spinal antinociceptive action of kappa opioid agonists in the adult and 21-day-old rat.
    Sullivan AF; Dickenson AH
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1119-25. PubMed ID: 2005577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
    Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
    Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
    J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy.
    Keïta H; Kayser V; Guilbaud G
    Eur J Pharmacol; 1995 Apr; 277(2-3):275-80. PubMed ID: 7493620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New kappa-receptor agonists based upon a 2-[(alkylamino)methyl]piperidine nucleus.
    Scopes DI; Hayes NF; Bays DE; Belton D; Brain J; Brown DS; Judd DB; McElroy AB; Meerholz CA; Naylor A
    J Med Chem; 1992 Feb; 35(3):490-501. PubMed ID: 1310743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
    Edwards SR; Mather LE; Smith MT
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): A peripheral efficacious kappa opioid agonist with unprecedented selectivity.
    Vanderah TW; Schteingart CD; Trojnar J; Junien JL; Lai J; Riviere PJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):326-33. PubMed ID: 14993260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of pravadoline: a new analgesic agent.
    Haubrich DR; Ward SJ; Baizman E; Bell MR; Bradford J; Ferrari R; Miller M; Perrone M; Pierson AK; Saelens JK
    J Pharmacol Exp Ther; 1990 Nov; 255(2):511-22. PubMed ID: 2243340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
    Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
    Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
    Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiles of the antinociceptive effect of R-84760, a selective kappa-opioid receptor agonist, in the formalin test in mice.
    Fujibayashi K; Iizuka Y
    Jpn J Pharmacol; 1995 May; 68(1):57-63. PubMed ID: 7494383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats.
    Walker J; Catheline G; Guilbaud G; Kayser V
    Pain; 1999 Dec; 83(3):509-516. PubMed ID: 10568859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
    Rorick-Kehn LM; Witkin JM; Statnick MA; Eberle EL; McKinzie JH; Kahl SD; Forster BM; Wong CJ; Li X; Crile RS; Shaw DB; Sahr AE; Adams BL; Quimby SJ; Diaz N; Jimenez A; Pedregal C; Mitch CH; Knopp KL; Anderson WH; Cramer JW; McKinzie DL
    Neuropharmacology; 2014 Feb; 77():131-44. PubMed ID: 24071566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
    Zhou L; Zhang Q; Stein C; Schäfer M
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain.
    Khalefa BI; Mousa SA; Shaqura M; Lackó E; Hosztafi S; Riba P; Schäfer M; Ferdinandy P; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2013 Aug; 713(1-3):54-7. PubMed ID: 23665110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.